This was the stock's fourth consecutive day of losses.
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...
Henry Schein, Inc., has announced that Stanley M. Bergman, chairman of the board and CEO, has received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current ...
NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results